BRTX
BioRestorative Therapies, Inc.$2.71+0.02 (+0.74%)Prev Close$2.69·MCap$2.1M·P/E—·Vol25.0K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
BRTX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Broadrick Dale | 10% Owner | Sell | 1,112 | $1.58 | $1.8K | 0 |
| Apr 8, 2024 | Silva Francisco | VP of Research and Development | Buy | 8,308 | $1.23 | $10.2K | 0 |
| Mar 18, 2024 | ALSTODT LANCE | President, CEO, COB | Sell | 17,633 | $1.39 | $24.5K | 0 |
| Mar 18, 2024 | Silva Francisco | VP of Research and Development | Sell | 17,193 | $1.39 | $23.9K | 0 |
| Feb 8, 2024 | Broadrick Dale | 10% Owner | Buy | 160,000 | $1.29 | $206.0K1.8% OS | 0 |
| Feb 7, 2024 | Broadrick Dale | 10% Owner | Buy | 120,000 | $1.35 | $162.3K1.4% OS | 0 |
| Dec 1, 2023 | Broadrick Dale | 10% Owner | Sell | 250 | $1.88 | $469.25 | 0 |
| Nov 27, 2023 | Broadrick Dale | 10% Owner | Sell | 278 | $1.89 | $525.42 | 0 |
| Sep 15, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 2,200 | $1.70 | $3.7K | 0 |
| Sep 14, 2023 | Broadrick Dale | 10% Owner | Buy | 20,000 | $1.60 | $32.0K | 0 |
| Sep 13, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 800 | $1.53 | $1.2K | 0 |
| Sep 6, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 2,887 | $1.96 | $5.7K | 0 |
| Aug 31, 2023 | Silva Francisco | VP of Research and Development | Buy | 4,954 | $2.22 | $11.0K | 0 |
| Jul 28, 2023 | Broadrick Dale | 10% Owner | Buy | 2,500 | $2.07 | $5.2K | 0 |
| Jul 27, 2023 | Broadrick Dale | 10% Owner | Buy | 1,000 | $2.80 | $2.8K | 0 |
| Jul 25, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 4,200 | $2.44 | $10.2K | 0 |
| Mar 31, 2023 | Silva Francisco | VP of Research and Development | Buy | 747 | $3.56 | $2.7K | 0 |
| Mar 20, 2023 | Silva Francisco | VP of Research and Development | Sell | 6,729 | $2.92 | $19.6K | 0 |
| Feb 18, 2023 | Silva Francisco | VP of Research and Development | Sell | 374 | $2.99 | $1.1K | 0 |
| Feb 1, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 400 | $3.10 | $1.2K | 0 |
| Jan 27, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.01 | $602.00 | 0 |
| Jan 20, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.14 | $627.00 | 0 |
| Jan 18, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 400 | $3.11 | $1.2K | 0 |
| Jan 9, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.08 | $308.00 | 0 |
| Dec 23, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 300 | $3.01 | $903.00 | 0 |
| Dec 7, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 1,800 | $2.99 | $5.4K | 0 |
| Nov 30, 2022 | Broadrick Dale | 10% Owner | Buy | 6,200 | $2.86 | $17.7K | 0 |
| Nov 21, 2022 | Silva Francisco | VP of Research and Development | Buy | 943 | $2.62 | $2.5K | 0 |
| Nov 18, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 1,000 | $2.88 | $2.9K | 0 |
| Oct 12, 2022 | Silva Francisco | VP of Research and Development | Buy | 725 | $3.39 | $2.5K | 0 |
| Oct 11, 2022 | Silva Francisco | VP of Research and Development | Buy | 806 | $3.69 | $3.0K | 0 |
| Sep 23, 2022 | Broadrick Dale | 10% Owner | Buy | 300 | $2.83 | $848.97 | 0 |
| Sep 22, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $2.92 | $584.00 | 0 |
| Aug 26, 2022 | Silva Francisco | VP of Research and Development | Buy | 5,723 | $3.28 | $18.8K | 0 |
| Aug 26, 2022 | Silva Francisco | VP of Research and Development | Sell | 3,958 | $3.39 | $13.4K | 0 |
| Jul 12, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 700 | $2.95 | $2.1K | 0 |
| Jul 6, 2022 | Broadrick Dale | 10% Owner | Buy | 1,200 | $3.01 | $3.6K | 0 |
| Jun 30, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 1,100 | $3.10 | $3.4K | 0 |
| Jun 30, 2022 | Broadrick Dale | 10% Owner | Buy | 1,900 | $3.08 | $5.8K | 0 |
| Jun 17, 2022 | Broadrick Dale | 10% Owner | Buy | 700 | $3.79 | $2.6K | 0 |
| Jun 16, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 600 | $3.73 | $2.2K | 0 |
| Jun 15, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 700 | $3.68 | $2.6K | 0 |
| Jun 15, 2022 | Broadrick Dale | 10% Owner | Buy | 3,200 | $3.77 | $12.1K | 0 |
| Jun 15, 2022 | Kristal Robert Eugene | Chief Financial Officer | Buy | 194 | $3.61 | $700.34 | 0 |
| Jun 14, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 500 | $3.91 | $2.0K | 0 |
| Jun 13, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.95 | $790.00 | 0 |
| Jun 13, 2022 | Broadrick Dale | 10% Owner | Buy | 1,300 | $3.92 | $5.1K | 0 |
| Jun 9, 2022 | Broadrick Dale | 10% Owner | Buy | 1,600 | $4.25 | $6.8K | 0 |
| Jun 8, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $4.28 | $428.00 | 0 |
| Jun 7, 2022 | Broadrick Dale | 10% Owner | Buy | 6,000 | $4.57 | $27.4K | 0 |
Showing 1–50 of 73
1 / 2
BRTX Insider Buying Activity
The following table shows recent insider purchases of BioRestorative Therapies, Inc. (BRTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | Silva Francisco | VP of Research and Development | Buy | 8,308 | $1.23 | $10.2K | 0 |
| Feb 8, 2024 | Broadrick Dale | 10% Owner | Buy | 160,000 | $1.29 | $206.0K1.8% OS | 0 |
| Feb 7, 2024 | Broadrick Dale | 10% Owner | Buy | 120,000 | $1.35 | $162.3K1.4% OS | 0 |
| Sep 15, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 2,200 | $1.70 | $3.7K | 0 |
| Sep 14, 2023 | Broadrick Dale | 10% Owner | Buy | 20,000 | $1.60 | $32.0K | 0 |
| Sep 13, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 800 | $1.53 | $1.2K | 0 |
| Sep 6, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 2,887 | $1.96 | $5.7K | 0 |
| Aug 31, 2023 | Silva Francisco | VP of Research and Development | Buy | 4,954 | $2.22 | $11.0K | 0 |
| Jul 28, 2023 | Broadrick Dale | 10% Owner | Buy | 2,500 | $2.07 | $5.2K | 0 |
| Jul 27, 2023 | Broadrick Dale | 10% Owner | Buy | 1,000 | $2.80 | $2.8K | 0 |
| Jul 25, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 4,200 | $2.44 | $10.2K | 0 |
| Mar 31, 2023 | Silva Francisco | VP of Research and Development | Buy | 747 | $3.56 | $2.7K | 0 |
| Feb 1, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 400 | $3.10 | $1.2K | 0 |
| Jan 27, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.01 | $602.00 | 0 |
| Jan 20, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.14 | $627.00 | 0 |
| Jan 18, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 400 | $3.11 | $1.2K | 0 |
| Jan 9, 2023 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $3.08 | $308.00 | 0 |
| Dec 23, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 300 | $3.01 | $903.00 | 0 |
| Dec 7, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 1,800 | $2.99 | $5.4K | 0 |
| Nov 30, 2022 | Broadrick Dale | 10% Owner | Buy | 6,200 | $2.86 | $17.7K | 0 |
| Nov 21, 2022 | Silva Francisco | VP of Research and Development | Buy | 943 | $2.62 | $2.5K | 0 |
| Nov 18, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 1,000 | $2.88 | $2.9K | 0 |
| Oct 12, 2022 | Silva Francisco | VP of Research and Development | Buy | 725 | $3.39 | $2.5K | 0 |
| Oct 11, 2022 | Silva Francisco | VP of Research and Development | Buy | 806 | $3.69 | $3.0K | 0 |
| Sep 23, 2022 | Broadrick Dale | 10% Owner | Buy | 300 | $2.83 | $848.97 | 0 |
| Sep 22, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $2.92 | $584.00 | 0 |
| Aug 26, 2022 | Silva Francisco | VP of Research and Development | Buy | 5,723 | $3.28 | $18.8K | 0 |
| Jul 12, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 700 | $2.95 | $2.1K | 0 |
| Jul 6, 2022 | Broadrick Dale | 10% Owner | Buy | 1,200 | $3.01 | $3.6K | 0 |
| Jun 30, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 1,100 | $3.10 | $3.4K | 0 |
| Jun 30, 2022 | Broadrick Dale | 10% Owner | Buy | 1,900 | $3.08 | $5.8K | 0 |
| Jun 17, 2022 | Broadrick Dale | 10% Owner | Buy | 700 | $3.79 | $2.6K | 0 |
| Jun 16, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 600 | $3.73 | $2.2K | 0 |
| Jun 15, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 700 | $3.68 | $2.6K | 0 |
| Jun 15, 2022 | Broadrick Dale | 10% Owner | Buy | 3,200 | $3.77 | $12.1K | 0 |
| Jun 15, 2022 | Kristal Robert Eugene | Chief Financial Officer | Buy | 194 | $3.61 | $700.34 | 0 |
| Jun 14, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 500 | $3.91 | $2.0K | 0 |
| Jun 13, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 200 | $3.95 | $790.00 | 0 |
| Jun 13, 2022 | Broadrick Dale | 10% Owner | Buy | 1,300 | $3.92 | $5.1K | 0 |
| Jun 9, 2022 | Broadrick Dale | 10% Owner | Buy | 1,600 | $4.25 | $6.8K | 0 |
| Jun 8, 2022 | ALSTODT LANCE | President, CEO, COB | Buy | 100 | $4.28 | $428.00 | 0 |
| Jun 7, 2022 | Broadrick Dale | 10% Owner | Buy | 6,000 | $4.57 | $27.4K | 0 |
BRTX Insider Selling Activity
The following table shows recent insider sales of BioRestorative Therapies, Inc. (BRTX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Broadrick Dale | 10% Owner | Sell | 1,112 | $1.58 | $1.8K | 0 |
| Mar 18, 2024 | ALSTODT LANCE | President, CEO, COB | Sell | 17,633 | $1.39 | $24.5K | 0 |
| Mar 18, 2024 | Silva Francisco | VP of Research and Development | Sell | 17,193 | $1.39 | $23.9K | 0 |
| Dec 1, 2023 | Broadrick Dale | 10% Owner | Sell | 250 | $1.88 | $469.25 | 0 |
| Nov 27, 2023 | Broadrick Dale | 10% Owner | Sell | 278 | $1.89 | $525.42 | 0 |
| Mar 20, 2023 | Silva Francisco | VP of Research and Development | Sell | 6,729 | $2.92 | $19.6K | 0 |
| Feb 18, 2023 | Silva Francisco | VP of Research and Development | Sell | 374 | $2.99 | $1.1K | 0 |
| Aug 26, 2022 | Silva Francisco | VP of Research and Development | Sell | 3,958 | $3.39 | $13.4K | 0 |
BRTX Insiders
Similar Stocks to BRTX
VRTX
Vertex Pharmaceuticals Incorporated
$512.49+0.81%
$131.05B
REGN
Regeneron Pharmaceuticals, Inc.
$797.47+1.61%
$81.33B
MRNA
Moderna, Inc.
$173.37+12.55%
$61.12B
RVMD
Revolution Medicines, Inc.
$193.47+1.30%
$41.87B
INSM
Insmed Incorporated
$121.58+1.32%
$26.01B
INCY
Incyte Corporation
$124.62-0.55%
$25.40B
UTHR
United Therapeutics Corporation
$493.80-0.21%
$21.00B
NBIX
Neurocrine Biosciences, Inc.
$144.33-1.29%
$14.70B